Shattuck Labs, Inc.
VSIG8-BASED CHIMERIC PROTEINS

Last updated:

Abstract:

The present invention relates, in part, to, chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.

Status:
Application
Type:

Utility

Filling date:

28 Oct 2019

Issue date:

5 Mar 2020